PE20010738A1 - Combinacion de un agente agonista o-2 y otro neuro-psicofarmaco para el tratamiento del sindrome de piernas inquietas - Google Patents
Combinacion de un agente agonista o-2 y otro neuro-psicofarmaco para el tratamiento del sindrome de piernas inquietasInfo
- Publication number
- PE20010738A1 PE20010738A1 PE2000000835A PE0008352000A PE20010738A1 PE 20010738 A1 PE20010738 A1 PE 20010738A1 PE 2000000835 A PE2000000835 A PE 2000000835A PE 0008352000 A PE0008352000 A PE 0008352000A PE 20010738 A1 PE20010738 A1 PE 20010738A1
- Authority
- PE
- Peru
- Prior art keywords
- combination
- legs syndrome
- psychopharmaco
- treatment
- restless legs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA COMBINACION DE SUSTANCIAS QUE COMPRENDE: a)DE 0,001mg-15mg DE UN AGONISTA O2 TAL COMO UN COMPUESTO IMIDAZOL DE PREFERENCIA DE 0,5mg A 10mg DE AZEPEXOL, BRIMONIDINA, DE 0,01mg A 1mg DE CLONIDINA, DEXMEDETOMIDINA, DE 0,05mg A 5mg DE LOFEXIDINA, MEDETOMIDINA, MOXOMIDINA, DE 0,05mg A 5mg DE RILMENIDINA, TALIPEXOL, DE 0,05mg A 7mg DE TIAMENIDINA, TIZANIDINA; b)UN NEUROPSICOFARMACO QUE REDUCE LOS SINTOMAS DEL SINDROME DE PIERNAS SUELTAS TAL COMO i)AGENTES AGONISTAS DE DOPAMINA (DE 1,25mg A 20mg DE BROMOCRIPTINA, DE 0,05mg A 5mg DE CABERGOLINA, DE 5mg A 60mg DE O-DIHIDRO-ERGOCRIPTINA, DE 0,1mg A 5mg DE LISURIDA, DE 0,05mg A 1mg DE PERGOLIDA, PIRIPEDIL, DE 0,01mg A 5mg DE PRAMIPEXOL, DE 0,2mg A 10mg DE ROPINIROL, S-(-)-2-(N-PROPIL-N-2-TIENIL-ETIL-AMINO)-5-HIDROXI-TETRALINA, (R)-5,6-DIHIDRO-5-(METILAMINO)-4H-IMIDAZO(4,5,1-ij)-QUINOLIN-2(1H)-ONA, BENZODIAZEPINAS (CLONAZEPAM, BROTIZOLAM, TEMAZEPAN, NITRAZEPAM, OXAZEPAM) O COMBINACION DE 10mg A 500mg DE L-DOPA Y DE 1mg A 100mg DE UN AGENTE INHIBIDOR DE DESCARBOXILASA TAL COMO BENSERAZIDINA O CARBIDOPA; OPIOIDE (BUPRENORFINA, DE 10mg A 100mg DE CODEINA, DEXTROPROPOXIFENO, DE 10mg A 100mg DE DIHIDROCODEINA, FENTANIL, HIDROMORFONA, LEVOMETADONA, MORFINA, DE 4,5mg A 20mg DE OXICODONA, PETIDINA, DE 65mg A 300 mg DE PROPOXIFENO, SUFENTANILO, TILIDINA, TRAMADOL, ENTRE OTROS)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19938823A DE19938823A1 (de) | 1999-08-19 | 1999-08-19 | Medikamentöse Behandlung des Restless Leg Syndroms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20010738A1 true PE20010738A1 (es) | 2001-07-16 |
Family
ID=7918572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000000835A PE20010738A1 (es) | 1999-08-19 | 2000-08-17 | Combinacion de un agente agonista o-2 y otro neuro-psicofarmaco para el tratamiento del sindrome de piernas inquietas |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20010053777A1 (es) |
| EP (1) | EP1210076A2 (es) |
| JP (1) | JP2003513014A (es) |
| KR (1) | KR20020020273A (es) |
| CN (1) | CN1368878A (es) |
| AR (1) | AR025329A1 (es) |
| AU (1) | AU6836500A (es) |
| BR (1) | BR0013355A (es) |
| CA (1) | CA2382648A1 (es) |
| CO (1) | CO5190708A1 (es) |
| CZ (1) | CZ2002516A3 (es) |
| DE (1) | DE19938823A1 (es) |
| IL (1) | IL147643A0 (es) |
| MX (1) | MXPA02001295A (es) |
| NO (1) | NO20020792L (es) |
| PE (1) | PE20010738A1 (es) |
| PL (1) | PL364871A1 (es) |
| SK (1) | SK2452002A3 (es) |
| TR (1) | TR200200450T2 (es) |
| UY (1) | UY26296A1 (es) |
| WO (1) | WO2001013903A2 (es) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2314893C (en) | 1997-12-22 | 2005-09-13 | Euro-Celtique, S.A. | Opioid agonist/antagonist combinations |
| US6375957B1 (en) | 1997-12-22 | 2002-04-23 | Euro-Celtique, S.A. | Opioid agonist/opioid antagonist/acetaminophen combinations |
| NZ522112A (en) * | 2000-04-21 | 2004-10-29 | Upjohn Co | Substituted phenylazacycloalkane-type compounds for treating fibromyalgia and chronic fatigue syndrome |
| KR20020089510A (ko) * | 2000-04-21 | 2002-11-29 | 파마시아 앤드 업존 캄파니 | 섬유 근육통 증후군 및 만성 피로 증후군의 치료 |
| US20070243240A9 (en) * | 2000-08-24 | 2007-10-18 | Fred Windt-Hanke | Transdermal therapeutic system |
| DE10066158B4 (de) * | 2000-08-24 | 2007-08-09 | Neurobiotec Gmbh | Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms |
| DE10041479A1 (de) | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923 |
| DE10053397A1 (de) * | 2000-10-20 | 2002-05-02 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
| AR031152A1 (es) * | 2000-10-31 | 2003-09-10 | Upjohn Co | Tratamientos nuevos para el sindrome de piernas inquietas |
| PT1380306E (pt) | 2001-03-30 | 2009-05-25 | Toray Industries | Medicamentos para psiconeurose |
| WO2002083141A1 (en) * | 2001-04-17 | 2002-10-24 | Pharmacia & Upjohn Company | Treatment of fibromyalgia and chronic fatigue syndrome |
| DE60238756D1 (de) | 2001-05-11 | 2011-02-10 | Endo Pharmaceuticals Inc | Opioid enthaltende arzneiform gegen missbrauch |
| US20030073609A1 (en) * | 2001-06-29 | 2003-04-17 | Pinkerton Thomas C. | Enhanced pharmacokinetic profile of intradermally delivered substances |
| DE10141650C1 (de) | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
| US20060263419A1 (en) * | 2002-03-12 | 2006-11-23 | Hans-Michael Wolff | Transdermal therapeutic system for Parkinson's Disease |
| EP1492506B2 (en) * | 2002-04-05 | 2016-06-29 | Euro-Celtique S.A. | Matrix for sustained, invariant and independent release of active compounds |
| DE10220230A1 (de) * | 2002-05-06 | 2003-11-27 | Sanol Arznei Schwarz Gmbh | Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms |
| PL372695A1 (en) * | 2002-06-19 | 2005-07-25 | Solvay Pharmaceuticals Gmbh | Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins |
| US8246979B2 (en) | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system for the administration of rotigotine |
| US8246980B2 (en) * | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system |
| DK1426049T3 (da) | 2002-12-02 | 2005-08-22 | Sanol Arznei Schwarz Gmbh | Iontophoretisk tilförsel af rotigotin til behandling af Parkinsons sygdom |
| DE10338174A1 (de) | 2003-08-20 | 2005-03-24 | Lts Lohmann Therapie-Systeme Ag | Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit |
| EP1604667A1 (en) * | 2004-06-08 | 2005-12-14 | Euro-Celtique S.A. | Opioids for the treatment of the restless leg syndrome |
| EP1604666A1 (en) | 2004-06-08 | 2005-12-14 | Euro-Celtique S.A. | Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD) |
| AU2006208627B8 (en) * | 2005-01-28 | 2009-08-13 | Mundipharma Pty Limited | Alcohol resistant dosage forms |
| EP1695700A1 (en) * | 2005-02-28 | 2006-08-30 | Euro-Celtique S.A. | Dosage form containing oxycodone and naloxone |
| EP1702558A1 (en) | 2005-02-28 | 2006-09-20 | Euro-Celtique S.A. | Method and device for the assessment of bowel function |
| EP1813276A1 (en) * | 2006-01-27 | 2007-08-01 | Euro-Celtique S.A. | Tamper resistant dosage forms |
| NZ571591A (en) | 2006-04-03 | 2011-09-30 | Teva Pharma | Use of rasagiline for the treatment of restless legs syndrome |
| US20100029618A1 (en) * | 2006-12-22 | 2010-02-04 | Gil Daniel W | Alpha-2 receptor pan agonist and anticonvulsant compositions for treating chronic pain |
| WO2009158477A1 (en) * | 2008-06-25 | 2009-12-30 | Us Worldmeds Llc | Skin patches and sustained-release formulations comprising lofexidine for transdermal and oral delivery |
| MX347106B (es) | 2009-03-10 | 2017-04-12 | Euro-Celtique S A * | Coposiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona. |
| US20180264013A1 (en) * | 2010-07-08 | 2018-09-20 | Wellesley Pharmaceuticals, Llc | Composition and methods for treating sleep disorders |
| CA2876203A1 (en) * | 2012-06-11 | 2013-12-19 | Psychogenics, Inc. | Use of eltoprazine in the treatment of motor and movement disorders associated with the treatment of parkinson's disease |
| CA2918004C (en) | 2013-07-23 | 2018-11-20 | Euro-Celtique S.A. | A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation |
| KR101827980B1 (ko) | 2013-10-07 | 2018-02-13 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 덱스메데토미딘 경피 전달 장치 및 이의 사용 방법 |
| ES2847936T3 (es) | 2013-10-07 | 2021-08-04 | Teikoku Pharma Usa Inc | Métodos y composiciones para el suministro transdérmico de una cantidad no sedante de dexmedetomidina |
| KR101831290B1 (ko) | 2013-10-07 | 2018-02-22 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 덱스메데토미딘 경피 조성물을 사용하여 주의력 결핍 과잉행동 장애, 불안 및 불면증을 치료하기 위한 방법 및 조성물 |
| EP3512600A4 (en) * | 2016-09-13 | 2020-05-27 | Mindlab LLC | DRUG COMBINATIONS AND TREATMENT OF RESTLESS LEG SYNDROME |
| LT3906927T (lt) * | 2020-05-04 | 2022-08-10 | Bioprojet Pharma | Dalinių dopamino d3 agonistų naudojimas centrinės nervų sistemos sutrikimams gydyti |
| CN115154448B (zh) * | 2022-08-04 | 2024-01-30 | 谭竞 | 一种治疗不宁腿综合征的药物及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4859685A (en) * | 1986-08-13 | 1989-08-22 | Boc, Inc. | Anesthetic composition and method of using the same |
| DE19749724A1 (de) * | 1997-11-11 | 1999-06-10 | Gruenenthal Gmbh | Verwendung einer Kombination aus Opioid und alpha-adrenergem Agonisten in Schmerzmitteln |
| SE9803760D0 (sv) * | 1998-11-04 | 1998-11-04 | Jan Hedner | Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel |
| WO2000054773A1 (en) * | 1999-03-12 | 2000-09-21 | Nitromed, Inc. | Dopamine agonists in combination with nitric oxide donors, compositions and methods of use |
-
1999
- 1999-08-19 DE DE19938823A patent/DE19938823A1/de not_active Withdrawn
-
2000
- 2000-08-09 KR KR1020027002101A patent/KR20020020273A/ko not_active Application Discontinuation
- 2000-08-09 WO PCT/EP2000/007719 patent/WO2001013903A2/de not_active Application Discontinuation
- 2000-08-09 CN CN00811555A patent/CN1368878A/zh active Pending
- 2000-08-09 BR BR0013355-8A patent/BR0013355A/pt active Pending
- 2000-08-09 AU AU68365/00A patent/AU6836500A/en not_active Abandoned
- 2000-08-09 SK SK245-2002A patent/SK2452002A3/sk unknown
- 2000-08-09 EP EP00956413A patent/EP1210076A2/de not_active Withdrawn
- 2000-08-09 MX MXPA02001295A patent/MXPA02001295A/es unknown
- 2000-08-09 CZ CZ2002516A patent/CZ2002516A3/cs unknown
- 2000-08-09 IL IL14764300A patent/IL147643A0/xx unknown
- 2000-08-09 JP JP2001518041A patent/JP2003513014A/ja active Pending
- 2000-08-09 PL PL00364871A patent/PL364871A1/xx not_active Application Discontinuation
- 2000-08-09 CA CA002382648A patent/CA2382648A1/en not_active Abandoned
- 2000-08-09 TR TR2002/00450T patent/TR200200450T2/xx unknown
- 2000-08-16 UY UY26296A patent/UY26296A1/es not_active Application Discontinuation
- 2000-08-17 PE PE2000000835A patent/PE20010738A1/es not_active Application Discontinuation
- 2000-08-18 CO CO00062316A patent/CO5190708A1/es not_active Application Discontinuation
- 2000-08-18 AR ARP000104291A patent/AR025329A1/es active Pending
-
2001
- 2001-08-01 US US09/919,731 patent/US20010053777A1/en not_active Abandoned
-
2002
- 2002-02-18 NO NO20020792A patent/NO20020792L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU6836500A (en) | 2001-03-19 |
| JP2003513014A (ja) | 2003-04-08 |
| CZ2002516A3 (cs) | 2002-05-15 |
| CA2382648A1 (en) | 2001-03-01 |
| CN1368878A (zh) | 2002-09-11 |
| EP1210076A2 (de) | 2002-06-05 |
| SK2452002A3 (en) | 2002-06-04 |
| PL364871A1 (en) | 2004-12-27 |
| US20010053777A1 (en) | 2001-12-20 |
| DE19938823A1 (de) | 2001-02-22 |
| AR025329A1 (es) | 2002-11-20 |
| IL147643A0 (en) | 2002-08-14 |
| CO5190708A1 (es) | 2002-08-29 |
| TR200200450T2 (tr) | 2002-08-21 |
| BR0013355A (pt) | 2002-04-30 |
| NO20020792D0 (no) | 2002-02-18 |
| UY26296A1 (es) | 2001-04-30 |
| MXPA02001295A (es) | 2002-08-12 |
| KR20020020273A (ko) | 2002-03-14 |
| NO20020792L (no) | 2002-02-18 |
| WO2001013903A3 (de) | 2001-08-23 |
| WO2001013903A2 (de) | 2001-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20010738A1 (es) | Combinacion de un agente agonista o-2 y otro neuro-psicofarmaco para el tratamiento del sindrome de piernas inquietas | |
| CA2331009A1 (en) | Compositions and methods of treatment for conditions responsive to testosterone elevation | |
| CO5680108A1 (es) | Compuestos para el tratamiento de la disfuncion sexual femenina | |
| TR199902646T2 (xx) | Seks�el bozuklu�un tedavisi i�in pirazolopirimidinonlar. | |
| TW200509924A (en) | Compositions of cyclooxygenase-2 selective inhibitors and 5-HT 1B/1D agonists for the treatment and prevention of migraine | |
| MA33984B1 (fr) | Stimulateurs de sgc ou activateurs de sgc seuls ou en combinaison avec des inhibiteurs de pde5 pour le traitement de la fibrose kystique | |
| MX2009009597A (es) | Derivados de amino-piridina como agonistas del receptor s1p1/edg1. | |
| WO2004091593A3 (en) | Methods for the treatment of pain comprising opioid antagonists | |
| PE20170666A1 (es) | 2-(morfolin-4-il)-1,7-naftiridinas | |
| CA2677691A1 (en) | Reducing side effects of tramadol | |
| CL2009001884A1 (es) | Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco. | |
| DE602005004312D1 (de) | Analgistische Darreichungsform, die nicht parenteral oder inhalation dosiert werden können | |
| CL2007001554A1 (es) | Compuestos derivados de pirido [3,2-e]pirazinas;inhibidoras de pde10;procedimiento de preparacion;composicion farmaceutica que comprende; kit farmaceutico; uso para preparar de un medicamento para tratar o prevenir trastornos asociados a la hiperactividad de pde10 y/o trastornos en los que inhibir la pde10 es de valor. | |
| TW200716122A (en) | Combination for the therapy of benign prostatic hyperplasia | |
| NZ752918A (en) | Treatment of prostate cancer | |
| MXPA03001737A (es) | Composiciones farmaceuticas para el dolor de cabeza, migrana, nausea y emesis. | |
| GEP20237476B (en) | N-substituted-dioxocyclobutenylamino-3-hydroxypicolinamides useful as ccr6 inhibitors | |
| NZ508912A (en) | Sustained matrix tablet containing trimetazidine and a cellulose ester polymer | |
| MY128896A (en) | Pharmaceutical combinations | |
| WO2001085150A3 (en) | Opioid antagonist containing composition for enchaching the potency or reducing adverse side effects ofopioid agonists | |
| UY28925A1 (es) | Nuevos derivados de aminopiridina y su uso como fármacos | |
| GT200000159A (es) | Sal polimorfica. | |
| UA93234C2 (ru) | Средство антимикробного действия, kotopoe содержит комплекс йода и диметилсульфоксида (дмсо) | |
| NZ610939A (en) | Novel antifungal 5,6-dihydro-4h-pyrrolo[1,2-a][1,4]- benzodiazepines and 6h-pyrrolo[1,2-a][1,4]benzodiazepines substituted with bicyclic benzene derivatives | |
| PE20040906A1 (es) | Derivados morfolinicos como agonistas de dopamina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |